Edgewise Therapeutics, Inc. (EWTX)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
39. 76
+1.57
+4.111%
$
4.27B Market Cap
- P/E Ratio
- Div Yield
744,700 Volume
-1.72 Eps
$ 38.19
Previous Close 
Want to track EWTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
EWTX Earnings Reports FAQ
What is the earnings per share (EPS) for EWTX?
The current EPS is -1.72.
What is the company's earnings growth rate?
Edgewise Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Edgewise Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Edgewise Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for EWTX at this time, as Edgewise Therapeutics, Inc has no recent EPS data to calculate it.
